Item Type | Name |
Academic Article
|
Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer.
|
Academic Article
|
Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-a)-positive breast cancer cells.
|
Academic Article
|
Endocrine disruptor regulation of microRNA expression in breast carcinoma cells.
|
Academic Article
|
Insulin-like growth factor-1 signaling regulates miRNA expression in MCF-7 breast cancer cell line.
|
Academic Article
|
In vitro and in vivo evaluation of novel anticancer agents in triple negative breast cancer models.
|
Academic Article
|
Proteomic signatures of acquired letrozole resistance in breast cancer: suppressed estrogen signaling and increased cell motility and invasiveness.
|
Academic Article
|
Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer.
|
Academic Article
|
Phytoalexins, miRNAs and breast cancer: a review of phytochemical-mediated miRNA regulation in breast cancer.
|
Academic Article
|
Benzimidazoles diminish ERE transcriptional activity and cell growth in breast cancer cells.
|
Academic Article
|
Glyceollin I Reverses Epithelial to Mesenchymal Transition in Letrozole Resistant Breast Cancer through ZEB1.
|
Academic Article
|
Protein Kinase CK2 Expression Predicts Relapse Survival in ERa Dependent Breast Cancer, and Modulates ERa Expression in Vitro.
|
Academic Article
|
Phytochemicals: Current strategies for treating breast cancer.
|
Academic Article
|
A novel and cost-effective ex vivo orthotopic model for the study of human breast cancer in mouse mammary gland organ culture.
|
Academic Article
|
Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole.
|
Academic Article
|
Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence.
|
Concept
|
Breast
|
Concept
|
Breast Neoplasms
|
Grant
|
Second line breast cancer therapy through a novel Phytoantiestrogen
|
Academic Article
|
The steroidal antiestrogen ICI 182,780 is an inhibitor of cellular aromatase activity.
|
Academic Article
|
Upregulation of AIB1, aromatase and ERa provides long-term estrogen-deprived human breast cancer cells with a mechanistic growth advantage for survival.
|
Academic Article
|
Upregulation of AIB1, aromatase and ERa provides long-term estrogen-deprived human breast cancer cells with a mechanistic growth advantage for survival.
|
Grant
|
Second line breast cancer therapy alters aromatase inhibitor resistant metastasis
|
Academic Article
|
Acquisition of Letrozole Resistance Through Activation of the p38/MAPK Signaling Cascade.
|
Academic Article
|
Quantitative Proteomic Profiling Identifies a Potential Novel Chaperone Marker in Resistant Breast Cancer.
|
Academic Article
|
Mammospheres of letrozole-resistant breast cancer cells enhance breast cancer aggressiveness.
|
Academic Article
|
Diallyl Sulfide Attenuation of Carcinogenesis in Mammary Epithelial Cells through the Inhibition of ROS Formation, and DNA Strand Breaks.
|
Academic Article
|
A Novel Allosteric Inhibitor Targets PLK1 in Triple Negative Breast Cancer Cells.
|
Academic Article
|
Glyceollins Trigger Anti-Proliferative Effects in Hormone-Dependent Aromatase-Inhibitor-Resistant Breast Cancer Cells through the Induction of Apoptosis.
|
Academic Article
|
Novel Therapeutic Combination Targets the Growth of Letrozole-Resistant Breast Cancer through Decreased Cyclin B1.
|
Academic Article
|
The Anticancer Effects of the Garlic Organosulfide Diallyl Trisulfide through the Attenuation of B[a]P-Induced Oxidative Stress, AhR Expression, and DNA Damage in Human Premalignant Breast Epithelial (MCF-10AT1) Cells.
|